InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Troutman William Wilson, Chief Financial Officer. Insider active across 1 companies, notably Eton Pharmaceuticals, Inc.. Cumulatively, 2 disclosures have been logged. Total volume traded: €38k. The latest transaction was disclosed on 20 August 2021 — Acquisition. Regulator: SEC (Form 4). All data is free.
Declarations2 total
€18,9705,000 shares@ €3.79390.0023% mcap100.0% of flow
Common Stock
SEC:0001493152-21-020809·
Ideal exit: 17 May 2022 (T+270)
€18,9705,000 shares@ €3.79390.0023% mcap50.0% of flow
Common Stock
SEC:0001493152-21-020809:0·
Ideal exit: 17 May 2022 (T+270)
2 of 2 declarations
About Troutman William Wilson
William Wilson Troutman is the Chief Financial Officer of Eton Pharmaceuticals, Inc. He is responsible for the financial management of the company, including financial planning, risk management, and regulatory compliance. With a strong background in finance, he plays a key role in the company's growth strategy and in optimizing financial resources. His expertise contributes to informed decision-making to ensure the sustainability and development of Eton Pharmaceuticals.
